ClinicalTrials.govpublic full text
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
nonalcoholic steatohepatitis (nash), non-alcoholic fatty liver disease (nafld), fibrosis, gs-9674, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 846047
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.